Key Financials –
FY2021 Earnings

FY2021 Revenue $275.9m +323% YoY
FY2021 Adjusted EBITDA
$40.9m
Forecast 2025 Revenue +$600m
Laboratory and rapid
at-home tests
22 million+

Prenetics Delivers Exceptional FY2021 Results as Company Completes Business Combination with Artisan Acquisition Corp. to list on Nasdaq Stock Exchange

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Press Releases

Recent Events

Featured Reports